Following transfection of HCC cells with the miR-124-3p.1 inhibitor, the protein levels of AKT2, p-AKT2, and p-FOXO3a were increased remarkably compared to the levels detected in the control group (Fig. 5A). The gene discussed is AKT2; the disease is hepatocellular carcinoma.